Creon 180000 [USP'U]/1

Creon 180000 [USP'U]/1 is a delayed-release pancreatic enzyme supplement designed to aid digestion. It contains pancrelipase, which helps break down fats, proteins, and carbohydrates. This medication is commonly used for individuals with exocrine pancreatic insufficiency.

Creon 180000 [USP'U]/1 is primarily used to manage digestive issues related to exocrine pancreatic insufficiency. This condition can occur due to various factors, including chronic pancreatitis, cystic fibrosis, or pancreatic surgery. The pancrelipase in Creon helps the body digest fats, proteins, and carbohydrates more effectively, supporting overall digestive health.

Common effects of Creon 180000 [USP'U]/1 may include improved digestion and reduced symptoms such as bloating, gas, and diarrhea. Some individuals may experience mild gastrointestinal discomfort or changes in bowel movements. It is important to follow the advice of a healthcare provider when using this medication.

Creon 180000 [USP'U]/1 should be taken with meals and snacks to ensure optimal effectiveness. It is important to swallow the capsules whole and not to crush or chew them. Individuals with certain medical conditions, such as bowel obstructions, should consult a healthcare provider before using this medication. Always store Creon in a cool, dry place away from direct sunlight.

Creon 180000 [USP'U]/1 may interact with certain medications, including antacids and other digestive enzymes. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Additionally, alcohol and certain foods may affect the absorption of pancrelipase, so it is advisable to follow a balanced diet and limit alcohol consumption.